Last Updated on June 7, 2024 by The Health Master
Gujarat FDCA
In a significant move to prioritize public health and ensure the safety and efficacy of medications, the Gujarat Food and Drug Control Administration (Gujarat FDCA) has revoked the licenses of seven private drug testing laboratories.
This decisive action follows a series of targeted inspections aimed at identifying and addressing non-compliance with critical quality control standards.
Risk-Based Inspections Uncover Violations
The Gujarat FDCA conducted risk-based inspections across 19 drug testing laboratories located in Ahmedabad, Baroda, and South Gujarat.
These inspections focused on verifying adherence to essential regulations related to:
- Impurities Testing: Ensuring the absence of harmful contaminants in medications.
- Reference Standards Validation: Guaranteeing the accuracy and reliability of testing procedures.
- Calibration: Maintaining the precision of analytical equipment.
- Testing Tools and Instrumentation: Verifying the functionality and proper use of drug testing laboratory instruments.
The inspections revealed significant violations in these areas, prompting the Gujarat FDCA to take decisive action.
Gujarat FDCA Commissioner Emphasizes Strict Compliance
Dr. H G Koshia, Commissioner of the Gujarat FDCA, elaborated on the findings and subsequent steps taken:
- “Out of the 54 drug testing laboratories operating in Gujarat, 19 underwent inspections. We identified serious non-compliance issues, leading to the issuance of stop-work orders and show-cause notices.”
- “Seven drug testing laboratories faced particularly severe violations and were subjected to stricter scrutiny. These drug testing laboratories will only be allowed to resume operations after demonstrably achieving full compliance with all regulations.”
Focus on Public Health and Drug Quality
Dr. Koshia further emphasized the importance of this initiative:
- “This crackdown underscores the Gujarat FDCA’s unwavering commitment to upholding the highest standards in drug testing processes. These procedures are vital for ensuring the safety and effectiveness of medications consumed by the public.”
- “The revocation of licenses serves as a strong message to all drug testing laboratories in the state. Strict adherence to regulatory requirements is paramount.”
Zero-Tolerance Policy and Ongoing Inspections
This action signifies the Gujarat FDCA’s zero-tolerance policy towards non-compliance in drug testing.
The initiative is part of a broader strategy to strengthen the reliability and integrity of the entire drug testing system within Gujarat, ultimately safeguarding public health.
The Gujarat FDCA has vowed to continue rigorous inspections across all remaining drug testing laboratories.
The affected drug testing laboratories must now implement corrective measures and demonstrate complete compliance with established norms before they can resume operations.
This decisive move is expected to serve as a wake-up call for all drug testing facilities in Gujarat, prompting them to reinforce their compliance frameworks and prioritize the highest quality standards in their practices.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Laboratory Waste Management, Types and Its Disposal
NABL certification procedure for Laboratories
Quality Assurance Vs Quality Control in the Pharma Industry
NABL certification for Laboratories: Let’s understand
Major FDA audit findings about Equipment and Instruments
Equipment and Instruments: Maintenance, difference and importance in the Pharma Industry
Upcoming events: Pharma, Cosmetics, Homoeopathy & Medical Devices
Cosmetics Testing in India: A Comprehensive Guide
Difference between Validation and Calibration in the Pharma Industry
Calibration of Laboratory Instruments
Difference: Disintegration and Dissolution test in pharma industry
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
Duties and responsibilities of QA person in Pharma Industry
Dissolution test: Importance in Pharma Industry
DCGI: Withdraw Cancer drug ‘Olaparib’ for these treatments
USFDA approval granted for Asthma Treatment Drug
USFDA inspection concluded at Solara Pharma without any observations
NPPA revised Ceiling price of 1 scheduled formulation: May 2024
FSSAI: Food Labelling and Display – Chapter-6
Indian Regulators Crack Down on Unapproved Antibiotics to Fight Misuse
CDSCO Committee to Revise Rule 64 for drug sales in India
One Nation-One Pharmacist Registration to Boost Recognition of Pharmacy Professionals
USFDA issued Form 483 with 6 observations to Lupin
Gujarat FDCA and IDMA Join Forces for GMP Compliance Training
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: